Analysts Offer Insights on Healthcare Companies: Taysha Gene Therapies (TSHA) and Zimmer Biomet Holdings (ZBH)
TipRanks01:30
Needham: Reiterates Taysha Gene Therapies (TSHA.US) rating and adjusted from buy to buy rating, target price is $7.00.
Zhitong Finance01:20
Taysha Gene Therapies Analyst Ratings
Benzinga01:18
Needham Reiterates Buy on Taysha Gene Therapies, Maintains $7 Price Target
Benzinga01:20
Cantor Fitzgerald Company: The Taysha Gene Therapies (TSHA.US) rating was reaffirmed and adjusted from an increase to an increase in holdings rating, with a target price of $7.00.
Zhitong FinanceApr 30 22:30
Taysha Gene Therapies Analyst Ratings
BenzingaApr 30 22:26
Taysha Gene Therapies Analyst Ratings
BenzingaApr 19 22:41
Cantor Fitzgerald Company: The Taysha Gene Therapies (TSHA.US) rating was reaffirmed and adjusted from an increase to an increase in holdings rating, with a target price of $7.00.
Zhitong FinanceApr 18 21:41
Taysha Gene Therapies Analyst Ratings
BenzingaApr 18 21:35
Needham: Reiterates Taysha Gene Therapies (TSHA.US) rating and adjusted from buy to buy rating, target price is $7.00.
Zhitong FinanceApr 11 18:31
Taysha Gene Therapies (TSHA.US) was covered for the first time by Piper Sandler, with an increase in holdings rating, with a target price of $9.00.
Zhitong FinanceApr 9 18:50
Taysha Gene Therapies Analyst Ratings
BenzingaApr 9 18:45
Piper Sandler Initiates Coverage On Taysha Gene Therapies With Overweight Rating, Announces Price Target of $9
BenzingaApr 9 18:47
Taysha Gene Therapies (TSHA) Gets a Buy From Truist Financial
TipRanksMar 28 20:16
Taysha Gene Therapies Analyst Ratings
BenzingaMar 21 23:36
Canaccord Genuity Reiterates Buy on Taysha Gene Therapies, Maintains $7 Price Target
BenzingaMar 21 23:37
Positive Clinical Trials Bolster Buy Rating for Taysha Gene Therapies
TipRanksMar 21 19:35
Analysts Offer Insights on Healthcare Companies: Taysha Gene Therapies (TSHA) and Viridian Therapeutics (VRDN)
TipRanksMar 21 18:40
Taysha Gene Therapies Analyst Ratings
BenzingaMar 21 16:48
Buy Rating on Taysha Gene Therapies Anchored by Promising TSHA-102 Clinical Data and Upcoming Pediatric Study Catalysts
TipRanksMar 21 14:38
No Data
No Data